A Study to Evaluate the Use of Resmetirom in Participants With MASLD and HIV
A Study to Evaluate the Use of Resmetirom in Participants With MASLD and HIV
Recruiting · NCT07143968 · Registry updated 2026-07-30Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study to Evaluate the Use of Resmetirom in Participants With MASLD and HIV | AIDS, Blood-Borne Infections, Genital Diseases, HIV infectious disease, Infections, RNA Virus Infections, Slow Virus Diseases, Urogenital Diseases, immune system disorder, inborn error of immunity, infectious disease, lentivirus infection, sexually transmitted disease, uterine carcinosarcoma, viral infectious disease, viral sexually transmitted disease | Recruiting | Phase 2 | 2026-07-30 | NCT07143968 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Naga P. Chalasani | 1 |
10 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Atlantic Clinical Research Institute | West Palm Beach | United States | 2 |
| Duke University Medical Center | Durham | United States | 505 |
| Indiana University | Indianapolis | United States | 160 |
| Johns Hopkins University | Baltimore | United States | 60 |
| Mt Sinai Health System | New York | United States | 1 |
| UC San Diego Altman Clinical and Translational Research Institute | La Jolla | United States | 3 |
| University of Alabama Birmingham | Birmingham | United States | 20 |
| University of California, San Francisco | San Francisco | United States | 294 |
| UT Health Houston | Houston | United States | 14 |
| Virginia Commonwealth University | Richmond | United States | 156 |